289 related articles for article (PubMed ID: 24420815)
41. Towards personalized medicine of colorectal cancer.
Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
[TBL] [Abstract][Full Text] [Related]
42. Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer.
Cao M; Wang Y; Lu G; Qi H; Li P; Dai X; Lu J
Curr Issues Mol Biol; 2022 Sep; 44(10):4447-4471. PubMed ID: 36286020
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
Yu M; Grady WM
Therap Adv Gastroenterol; 2012 Sep; 5(5):319-37. PubMed ID: 22973417
[TBL] [Abstract][Full Text] [Related]
44. Small-molecule drugs of colorectal cancer: Current status and future directions.
Yang Y; Liu P; Zhou M; Yin L; Wang M; Liu T; Jiang X; Gao H
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166880. PubMed ID: 37696461
[TBL] [Abstract][Full Text] [Related]
45. Colorectal cancer and NF-κB signaling pathway.
Hassanzadeh P
Gastroenterol Hepatol Bed Bench; 2011; 4(3):127-32. PubMed ID: 24834170
[TBL] [Abstract][Full Text] [Related]
46. Emerging Therapeutic Agents for Colorectal Cancer.
Nalli M; Puxeddu M; La Regina G; Gianni S; Silvestri R
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946546
[TBL] [Abstract][Full Text] [Related]
47. Progress of research on molecular targeted therapies for colorectal cancer.
Huang S; Ye J; Gao X; Huang X; Huang J; Lu L; Lu C; Li Y; Luo M; Xie M; Lin Y; Liang R
Front Pharmacol; 2023; 14():1160949. PubMed ID: 37614311
[TBL] [Abstract][Full Text] [Related]
48. Colorectal Cancer Subtypes - The Current Portrait.
Jordan P
Adv Exp Med Biol; 2018; 1110():1-6. PubMed ID: 30623362
[TBL] [Abstract][Full Text] [Related]
49. Peptides for diagnosis and treatment of colorectal cancer.
Shapira S; Fokra A; Arber N; Kraus S
Curr Med Chem; 2014; 21(21):2410-6. PubMed ID: 24524764
[TBL] [Abstract][Full Text] [Related]
50. Update in antiepidermal growth factor receptor therapy in the management of metastatic colorectal cancer.
Loong HH; Ma BB; Chan AT
J Oncol; 2009; 2009():967920. PubMed ID: 19365583
[TBL] [Abstract][Full Text] [Related]
51. Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status.
Lee JK; Chan AT
Curr Colorectal Cancer Rep; 2011 Jun; 7(2):136-144. PubMed ID: 21572547
[TBL] [Abstract][Full Text] [Related]
52. Muscarinic receptor signaling and colon cancer progression.
Xie G; Raufman JP
J Cancer Metastasis Treat; 2016 Jun; 2():195-200. PubMed ID: 32671227
[TBL] [Abstract][Full Text] [Related]
53. Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers.
Hwang K; Yoon JH; Lee JH; Lee S
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466394
[TBL] [Abstract][Full Text] [Related]
54. A review of controversies in the management of colorectal cancers.
Deo SV; Kapali AS; Gupta M; Shukla NK
Indian J Surg; 2012 Jun; 74(3):221-7. PubMed ID: 23730048
[TBL] [Abstract][Full Text] [Related]
55. New insights into the molecular pathogenesis of colorectal cancer.
Hung KE; Chung DC
Drug Discov Today Dis Mech; 2006; 3(4):439. PubMed ID: 20151020
[TBL] [Abstract][Full Text] [Related]
56. Current status and problems of molecular target therapy for colorectal cancer.
Tsuda T; Nakajima T; Boku N
Nihon Shokakibyo Gakkai Zasshi; 2011 Jan; 108(1):19-23. PubMed ID: 21212591
[No Abstract] [Full Text] [Related]
57. [New insights into molecular target therapy for colorectal cancer].
Kanemitsu K; Yamashita K; Sumi Y; Suzuki S; Tanaka K; Kakeji Y
Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2021-30. PubMed ID: 23221050
[No Abstract] [Full Text] [Related]
58. Which strategies will lead to progress in the management of colorectal cancer?
Goldberg RM
Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S33-6. PubMed ID: 19360145
[TBL] [Abstract][Full Text] [Related]
59. An Editorial View on the Special Issue "Colorectal Cancers: From Present Problems to Future Solutions".
Allgayer H
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205718
[TBL] [Abstract][Full Text] [Related]
60. Polymeric nanoparticles for colon cancer therapy: overview and perspectives.
You X; Kang Y; Hollett G; Chen X; Zhao W; Gu Z; Wu J
J Mater Chem B; 2016 Dec; 4(48):7779-7792. PubMed ID: 32263770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
